D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 145 Citations 80,642 413 World Ranking 763 National Ranking 459

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

Pathology, Carcinoma, Serous fluid, Serous carcinoma and Cancer are his primary areas of study. His work on Carcinoma in situ as part of general Pathology research is frequently linked to Pseudomyxoma peritonei, bridging the gap between disciplines. His Carcinoma research incorporates elements of Hyperplasia and Atypia.

His Serous fluid study integrates concerns from other disciplines, such as Ovarian carcinoma, Cystadenocarcinoma, Micropapillary Serous Carcinoma, Fallopian tube and Endometrial hyperplasia. The various areas that Robert J. Kurman examines in his Serous carcinoma study include Cancer research and KRAS. His Cancer research is multidisciplinary, incorporating perspectives in Guideline, Gynecology and Oncology.

His most cited work include:

  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial (1372 citations)
  • WHO classification of tumours of female reproductive organs (626 citations)
  • Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". (623 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Pathology, Serous fluid, Carcinoma, Serous carcinoma and Internal medicine. His study on Pathology also encompasses disciplines like

  • Ovary which is related to area like Ovarian tumor,
  • Adenocarcinoma together with Metastasis. His Serous fluid research is multidisciplinary, relying on both Cancer research, Fallopian tube and Ovarian cancer, Cystadenocarcinoma, Micropapillary Serous Carcinoma.

His Carcinoma research incorporates themes from Endometrium, Radiology and Hyperplasia. Robert J. Kurman has included themes like Carcinogenesis, Tumor progression, Serous Cystadenoma and Clear cell carcinoma in his Serous carcinoma study. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology, Gynecology and Oncology.

He most often published in these fields:

  • Pathology (65.49%)
  • Serous fluid (31.49%)
  • Carcinoma (25.44%)

What were the highlights of his more recent work (between 2009-2020)?

  • Pathology (65.49%)
  • Serous fluid (31.49%)
  • Serous carcinoma (22.17%)

In recent papers he was focusing on the following fields of study:

Robert J. Kurman focuses on Pathology, Serous fluid, Serous carcinoma, Carcinoma and Ovarian cancer. Robert J. Kurman studies Pathology, namely Immunohistochemistry. His Serous fluid study integrates concerns from other disciplines, such as Serous Tubal Intraepithelial Carcinoma, Cancer research, Gynecology and Cystadenocarcinoma.

He works mostly in the field of Serous carcinoma, limiting it down to topics relating to Serous Cystadenoma and, in certain cases, Serous tumour, as a part of the same area of interest. Robert J. Kurman works mostly in the field of Carcinoma, limiting it down to concerns involving Adenocarcinoma and, occasionally, Endometrium. In his study, Carcinosarcoma, Risk factor and Young adult is strongly linked to Oncology, which falls under the umbrella field of Ovarian cancer.

Between 2009 and 2020, his most popular works were:

  • WHO classification of tumours of female reproductive organs (626 citations)
  • Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women (448 citations)
  • The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. (416 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Serous fluid, Pathology, Fallopian tube, Ovarian cancer and Serous carcinoma are his primary areas of study. His Serous fluid study combines topics from a wide range of disciplines, such as Cancer research, Serous Tubal Intraepithelial Carcinoma, Ovarian carcinoma, Carcinoma and Cystadenocarcinoma. His Carcinoma study incorporates themes from Uterine Neoplasm, Somatic cell and Adenocarcinoma.

The study incorporates disciplines such as Telomere, Gestational trophoblastic disease and Ovary in addition to Pathology. His Fallopian tube study also includes fields such as

  • Endosalpingiosis that intertwine with fields like Tubal Hyperplasia, Hyperplasia, Ovarian tumor, Psammoma body and Serous tumour,
  • Peritoneum together with Serous Cystadenoma. His research in Ovarian cancer intersects with topics in Lamina propria, Metaplasia and Salpingitis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

F X Bosch;M M Manos;N Muñoz;M Sherman.
Journal of the National Cancer Institute (1995)

4626 Citations

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Diane Solomon;Diane Davey;Robert Kurman;Marianne Prey.
JAMA (2002)

4505 Citations

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen.
The New England Journal of Medicine (2007)

2751 Citations

WHO classification of tumours of female reproductive organs

Robert J. Kurman;Maria Luisa Carcangiu;C. Simon Herrington;Robert H. Young.
(2014)

2558 Citations

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Robert J. Kurman;Ie Ming Shih.
The American Journal of Surgical Pathology (2010)

2058 Citations

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade.
Lancet Oncology (2005)

1915 Citations

Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia

Mark H. Schiffman;Heidi M. Bauer;Robert N. Hoover;Andrew G. Glass.
Journal of the National Cancer Institute (1993)

1762 Citations

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

C.Paul Morrow;Brian N. Bundy;Robert J. Kurman;William T. Creasman.
Gynecologic Oncology (1991)

1629 Citations

Ovarian Tumorigenesis : A Proposed Model Based on Morphological and Molecular Genetic Analysis

Ie Ming Shih;Robert J. Kurman.
American Journal of Pathology (2004)

1564 Citations

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

A T Lorincz;R Reid;A B Jenson;M D Greenberg.
Obstetrics & Gynecology (1992)

1334 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert J. Kurman

Ie Ming Shih

Ie Ming Shih

Johns Hopkins University

Publications: 167

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 129

C. Blake Gilks

C. Blake Gilks

University of British Columbia

Publications: 112

Robert A. Soslow

Robert A. Soslow

Memorial Sloan Kettering Cancer Center

Publications: 107

Ben Davidson

Ben Davidson

Oslo University Hospital

Publications: 100

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 99

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 98

Chien-Fu Hung

Chien-Fu Hung

Johns Hopkins University

Publications: 98

David G. Huntsman

David G. Huntsman

University of British Columbia

Publications: 96

Christopher P. Crum

Christopher P. Crum

Brigham and Women's Hospital

Publications: 93

Mark E. Sherman

Mark E. Sherman

Mayo Clinic

Publications: 91

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 86

Susanne K. Kjaer

Susanne K. Kjaer

University of Copenhagen

Publications: 85

Luisa L. Villa

Luisa L. Villa

Universidade de São Paulo

Publications: 83

Suzanne M. Garland

Suzanne M. Garland

University of Melbourne

Publications: 80

Esther Oliva

Esther Oliva

Harvard University

Publications: 77

Trending Scientists

Jordi J. Mallorqui

Jordi J. Mallorqui

Universitat Politècnica de Catalunya

Lutz Tobiska

Lutz Tobiska

Otto-von-Guericke University Magdeburg

Michael Bosse

Michael Bosse

ETH Zurich

Hamidreza Modares

Hamidreza Modares

Michigan State University

Gregory L. Hillhouse

Gregory L. Hillhouse

University of Chicago

Jeremy M. Boss

Jeremy M. Boss

Emory University

Patrik Nosil

Patrik Nosil

University of Montpellier

Kevin J. Rice

Kevin J. Rice

University of California, Davis

José Luis Benedito

José Luis Benedito

University of Santiago de Compostela

John W. Sedat

John W. Sedat

University of California, San Francisco

Bernhard Fleckenstein

Bernhard Fleckenstein

University of Erlangen-Nuremberg

Paul D. Asimow

Paul D. Asimow

California Institute of Technology

Terje Gobakken

Terje Gobakken

Norwegian University of Life Sciences

John Poté

John Poté

University of Geneva

William C. Gause

William C. Gause

Rutgers, The State University of New Jersey

Thomas Sandström

Thomas Sandström

Umeå University

Something went wrong. Please try again later.